医学
耐受性
结肠镜检查
肠道准备
胃肠病学
随机对照试验
内科学
不利影响
临床试验
退出时间
结直肠癌
癌症
作者
Peng Pan,Shengbing Zhao,Rundong Wang,Shuling Wang,Hongxin Sun,Tian Xia,Xin Chang,Lun Gu,Zhao‐Shen Li,Yu Bai
出处
期刊:Chinese Journal of Digestive Endoscopy
日期:2019-12-20
卷期号:36 (12): 923-927
标识
DOI:10.3760/cma.j.issn.1007-5232.2019.12.010
摘要
Objective
To evaluate the clinical value of a commercial low-residue diet (LRD) for bowel preparation of colonoscopy.
Methods
This study was a prospective, endoscopist-blind, and randomized controlled trial. Participants were randomly assigned to two groups according to administration of LRD: the experimental group and the control group. Bowel preparation quality, compliance and tolerability of the two groups were compared.
Results
A total of 61 patients were enrolled, with 32 in the experimental group and 29 in the control group. The outcomes were as follows: Boston Bowel Preparation Scale (BBPS) (7.8±1.0 VS 7.1±1.3, P=0.037), the rate of bowel preparation adequacy (87.5% VS 79.3%, P=0.388), compliance rate of dietary restriction (78.1% VS 55.2%, P=0.057), preparation completion rate (93.8% VS 93.1%, P=0.919), cecal intubation rate (both were 100.0%) and cecum arrival time (9.1±2.9 min VS 9.8±3.7 min, P=0.417), incidence of adverse (3.1% VS 3.4%, P=0.944), and hunger rate before colonoscopy (34.4% VS 48.3%, P=0.102).
Conclusion
The LRD for bowel preparation of colonoscopy significantly improves BBPS, but its effect on improving the bowel preparation adequacy, patient compliance and tolerability needs to be confirmed by further larger-scale trials.
Key words:
Colonoscopy; Enteral nutrition; Food, formulated; Recommended dietary allowances; Bowel preparation
科研通智能强力驱动
Strongly Powered by AbleSci AI